Holen Sie sich die Stockscreener-App
1.785
3.51%
-0.065
Schlusskurs vom Vortag:
$1.85
Offen:
$1.91
24-Stunden-Volumen:
112.41K
Relative Volume:
0.26
Marktkapitalisierung:
$258.44M
Einnahmen:
$18.67M
Nettoeinkommen (Verlust:
$-64.78M
KGV:
-3.0941
EPS:
-0.5769
Netto-Cashflow:
$-37.02M
1W Leistung:
-5.56%
1M Leistung:
+5.00%
6M Leistung:
+8.84%
1J Leistung:
-44.39%
1-Tages-Spanne:
$1.78
$1.91
1-Wochen-Bereich:
$1.78
$2.035
52-Wochen-Spanne:
$1.22
$3.34
Omniab Inc Stock (OABI) Company Profile
Firmenname
Omniab Inc
Sektor
Branche
Telefon
510-250-7800
Adresse
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.785 | 267.85M | 18.67M | -64.78M | -37.02M | -0.5769 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.75 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.28 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
703.21 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.43 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.37 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-04-21 | Eingeleitet | The Benchmark Company | Buy |
| 2023-04-13 | Eingeleitet | Craig Hallum | Buy |
| 2023-02-22 | Eingeleitet | Cowen | Outperform |
| 2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-20 | Eingeleitet | Truist | Buy |
| 2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
| 2022-11-29 | Eingeleitet | SVB Leerink | Outperform |
| 2022-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Omniab Inc Aktie (OABI) Neueste Nachrichten
Earnings call transcript: OmniAb beats Q4 2025 EPS forecast, stock rises - Investing.com Nigeria
Earnings Miss: Will OmniAb Inc Equity Warrant benefit from rising consumer demandEarnings Performance Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
OmniAb outlines $25M–$30M 2026 revenue guidance as partner pipeline accelerates with OmniUltra and xPloration launches - MSN
OmniAb Earnings Call Highlights Platform Growth, Cash Path - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: OmniAb (OABI) and Cresco Labs (OtherCRLBF) - The Globe and Mail
Q1 Earnings Forecast for OmniAb Issued By HC Wainwright - MarketBeat
OmniAb (NASDAQ:OABI) Upgraded to Hold at Wall Street Zen - MarketBeat
Craig-Hallum Reaffirms Their Buy Rating on OmniAb (OABI) - The Globe and Mail
Benchmark Maintains Buy on OmniAb, Inc. (OABI) March 2026 - Meyka
US Market Wrap: Is OmniAb Inc stock undervalued right now2025 Key Lessons & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Revenue Check: Does OmniAb Inc stock have upside surprise potential - baoquankhu1.vn
Benchmark reiterates Buy on OmniAb stock, keeps $4 target - Investing.com
Benchmark reiterates Buy on OmniAb stock, keeps $4 target By Investing.com - Investing.com UK
OmniAb, Inc. (NASDAQ:OABI) Q4 2025 Earnings Call Transcript - Insider Monkey
HC Wainwright Estimates OmniAb's Q2 Earnings (NASDAQ:OABI) - MarketBeat
OmniAb (OABI) Receives a Buy from Stifel Nicolaus - The Globe and Mail
Weekly Earnings: Will OmniAb Inc Equity Warrant benefit from rising consumer demand2025 Growth vs Value & Weekly Breakout Watchlists - baoquankhu1.vn
OmniAb Q4 2025 slides: revenue dips but pipeline hits 407 programs - Investing.com Australia
Stifel reiterates Buy rating on OmniAb stock, cites partner growth By Investing.com - Investing.com Australia
Stifel reiterates Buy rating on OmniAb stock, cites partner growth - Investing.com India
OmniAb, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
OmniAb Q4 2025 slides: revenue dips but pipeline hits 407 programs By Investing.com - Investing.com South Africa
OmniAb Q4 2025 Earnings Call Transcript - MarketBeat
OmniAb Q4 Earnings Call Highlights - MarketBeat
OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates - Bitget
OmniAb Inc (NASDAQ:OABI) Reports Q4 and Full-Year 2025 Earnings Miss, Provides 2026 Outlook - ChartMill
OABI: 107 partners, 407 programs, new tech launches, and 2026 revenue rebound expected - TradingView
OmniAb Reports $50.3 Million Revenue for 2025 with 15% Annual Growth and Expanded Partnerships - geneonline.com
OmniAb (NASDAQ:OABI) Issues Earnings Results - MarketBeat
OmniAb (NASDAQ: OABI) outlines 2026 guidance after lower 2025 revenue - Stock Titan
OmniAb Q4 Earnings Assessment - Benzinga
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - Business Wire
A Look Ahead: OmniAb's Earnings Forecast - Benzinga
OmniAb Inc (OABI) Q4 2025 Earnings Report Preview: What To Expec - GuruFocus
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION), OmniAb (OABI) and Astrana Health (ASTH) - The Globe and Mail
OmniAb Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
OmniAb (OABI) Projected to Post Earnings on Wednesday - Defense World
OmniAb to Participate at the Leerink Partners Global Healthcare Conference - BioSpace
OABIW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MACD Signal: Will PFAI benefit from AI trends2025 Trade Ideas & Safe Capital Growth Stock Tips - baoquankhu1.vn
Will OmniAb Inc. Equity Warrant outperform its industry peersJuly 2025 Sentiment & Verified Entry Point Detection - mfd.ru
Is OmniAb Inc. benefiting from innovation trendsEarnings Summary Report & Consistent Return Strategy Ideas - mfd.ru
Why OmniAb Inc. Equity Warrant stock is a must watch in 2025July 2025 Gainers & Free Weekly Chart Analysis and Trade Guides - mfd.ru
OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 - BioSpace
Matthew Foehr Sells 30,843 Shares of OmniAb (NASDAQ:OABI) Stock - MarketBeat
OmniAb (NASDAQ:OABI) Insider Charles Berkman Sells 9,673 Shares - MarketBeat
Insider Selling: OmniAb (NASDAQ:OABI) CFO Sells 9,301 Shares of Stock - MarketBeat
Merger Talk: Is OmniAb Inc stock undervalued right nowPortfolio Update Report & Smart Investment Allocation Tips - baoquankhu1.vn
Surprises Report: Is OmniAb Inc benefiting from innovation trendsGlobal Markets & Free Community Supported Trade Ideas - baoquankhu1.vn
Matthew Foehr Sells 20,754 Shares of OmniAb (NASDAQ:OABI) Stock - MarketBeat
Insider Selling: OmniAb (NASDAQ:OABI) Insider Sells 6,990 Shares of Stock - MarketBeat
Finanzdaten der Omniab Inc-Aktie (OABI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):